SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

TELA Bio Reports Third-Quarter 2026 Financial Results

TELA Bio reported third-quarter 2026 financial results and said it reduced its sequential operating loss by 21%.

TELA

Story updates

09:02:00 PM UTC
SquawkNews
TELA Bio reported Q3 2026 revenue of $19.0M, down 8% from $20.7M a year earlier. Adjusted EBITDA loss was $3.4M, versus $5.7M in Q3 2025; cash and cash equivalents were $22.7M at September 30, 2026.Material DetailsContext by AI AnalystThis quarter shows revenue pressure alongside improving adjusted…

Related stories